Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for DBV Technologies S.A. [DBVT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated31 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

-2.25% $ 0.560

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults...

Stats
Today's Volume 1.07M
Average Volume 79 146.00
Market Cap 122.56M
EPS $0 ( 2024-05-09 )
Next earnings date ( $-0.130 ) 2024-07-29
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.370
ATR14 $0.00700 (1.27%)
Insider Trading
Date Person Action Amount type
2024-05-22 Mohideen Pharis Sell 382 Ordinary Shares
2024-05-24 Mohideen Pharis Sell 660 Ordinary Shares
2024-03-08 Tasse Daniel Buy 17 094 Ordinary Shares
2024-02-06 Ndu Adora Buy 1 825 Ordinary Shares
2023-11-22 Mohideen Pharis Sell 2 245 Ordinary Shares
INSIDER POWER
99.70
Last 59 transactions
Buy: 29 162 445 | Sell: 1 081 448

Volume Correlation

Long: -0.43 (neutral)
Short: 0.39 (neutral)
Signal:(47.564) Neutral

DBV Technologies S.A. Correlation

10 Most Positive Correlations
OZEM1
JACK0.954
ALLR0.944
MBIO0.94
VEEE0.938
APVO0.936
MPAA0.935
BSBK0.934
VRSN0.932
OSUR0.932
10 Most Negative Correlations
NKTR-0.951
INCR-0.945
VCTR-0.944
AEYE-0.943
HYAC-0.941
GGAL-0.939
CSLM-0.938
PAYS-0.936
PRIM-0.936
SMTC-0.933

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

DBV Technologies S.A. Correlation - Currency/Commodity

The country flag 0.08
( neutral )
The country flag 0.09
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.60
( weak )
The country flag -0.51
( weak negative )

DBV Technologies S.A. Financials

Annual 2023
Revenue: $15.73M
Gross Profit: $20.23M (128.59 %)
EPS: $-0.760
FY 2023
Revenue: $15.73M
Gross Profit: $20.23M (128.59 %)
EPS: $-0.760
FY 2022
Revenue: $4.80M
Gross Profit: $-16.53M (-344.46 %)
EPS: $-0.620
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.890

Financial Reports:

No articles found.

DBV Technologies S.A. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

DBV Technologies S.A.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The milk-induced company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA); Viaskin Egg, a pre-clinical stage product for the treatment of hen's egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.3553080558777 seconds
Number of API calls: 2
Number of DB calls: 8